Robert Gut

CIK 1716268 · Chief Medical Officer · last filed 2026-06-12

Robert Gut is a Chief Medical Officer who has filed 33 SEC Form 4 insider transactions across 2 companies since 2017. The most recent filing, for QURE, was dated Jun 12, 2026. Across all open-market trades the lifetime net is −$5.0M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $1.3M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$1.28M

Companies

2

Total Filings

33

Lifetime Open-Market Net

-$4.96M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
QURE Director 32,342 $39.71 $1.28M -$4.96M 26 2026-06-12
Aravive, Inc. (VSAR) Delisted Chief Medical Officer 37,883 $0 3 2017-12-22

Recent Filings

33 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-06-12 QURE Mixed −83 -$228.1K EDGAR
2026-06-11 QURE Notice (144) −2,726 -$73.8K EDGAR
2026-06-10 QURE Notice (144) −7,552 -$196.7K EDGAR
2026-01-14 QURE Mixed −7,803 -$379.7K EDGAR
2026-01-12 QURE Notice (144) −25,613 -$676.7K EDGAR
2025-11-10 QURE Mixed −15,594 -$784.5K EDGAR
2025-11-06 QURE Notice (144) −31,434 -$819.2K EDGAR
2025-06-24 QURE Sell (S) −3,336 -$48.2K EDGAR
2025-06-13 QURE Grant (A) +7,970 $0 EDGAR
2024-06-21 QURE Grant (A) +8,080 $0 EDGAR
Showing 110 of 33
Page 1 of 4
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.